Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

NICE rejects Elil Lilly’s Verzenio for breast cancer in draft guidance

October 19, 2018 Medical Communications, Sales and Marketing Eli Lilly, NICE, UK, Verzenios, breast cancer, pharma

Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that …
News

Hearing loss and inner ear disorders: The next frontier for pharmaceutical success?

October 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sensorion, hearing loss, inner ear disorders, opinion, pharma

Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …
Feature

Novartis snaps up cancer drug developer Endocyte for $2.1 billion

October 18, 2018 Research and Development, Sales and Marketing Cancer, Endocyte, Novartis, pharma

Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology …
News

MHRA to extend EpiPen expiry dates to tackle shortages

October 18, 2018 Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen

The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …
News

Pfizer announce cull of 2% of staff

October 18, 2018 Business Services, Medical Communications, Sales and Marketing Bourla, Ian Read, Jobs, Pfizer, america, layoffs

US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year. The company …
News

Samsung and Bioepis launch third Humira biosimilar in Europe

October 17, 2018 Research and Development, Sales and Marketing Amgen, Biogen, Humira, Imraldi, Samusng Bioepis, pharma

Hot on the heels of Amgen, Samsung Bioepis and Biogen have announced the launch of their own biosimilar version of …
News

FDA approves Pfizer’s Talzenna for breast cancer alongside tool to identify eligible patients

October 17, 2018 Research and Development, Sales and Marketing Cancer, FDA, Pfizer, Talzenna, breast cancer, pharma

Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to …
News

Roche’s Kadcyla beats Herceptin breast cancer disease recurrence and death risk

October 16, 2018 Manufacturing and Production, Sales and Marketing Cancer, Kadcyla, Roche, breast cancer, pharma

Roche has unveiled new data for its antibody-drug conjugate Kadcyla (trastuzumab emtansine) in the treatment of patients with HER2-positive early …
News

Amgen launches first biosimilar of best-selling Humira in Europe

October 16, 2018 Manufacturing and Production, Sales and Marketing Amgen, Amgevita, Humira, biosimilar, pharma

Amgen has announced the launch of a proprietary biosimilar version of Abbvie’s best-selling drug Humira (adalimumab) across all European markets, …
News

MSD and Samsung Bioepis terminate development of Lantus biosimilar for diabetes

October 15, 2018 Research and Development, Sales and Marketing Lantus, MSD, Samsung Bioepis, Sanofi, biosimilar, diabetes, pharma

MSD has reportedly terminated a previous agreement with Samsung Bioepis which would have seen them collaborate on a biosimilar version …
News

AI, big data: Making a case for faster drug discovery

October 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …
Feature

FDA advisory panel approves AcelRx’s opioid pain drug Dsuvia

October 15, 2018 Sales and Marketing FDA, approval, comittee, opioids

An FDA advisory panel voted 10 to 3 to recommend the approval of AcelRx Pharmaceuticals’ opioid pain drug Dsuvia (sufentanil) …
News

Digital system may prevent £300m prescription fraud losses for NHS by 2020

October 15, 2018 Sales and Marketing NHS, fraud, government, prescription fraud, uk politics

The British government are launching a new digitised system aimed at cracking down on prescription fraud in the NHS. However …
News

BMS’ Opdivo fails to improve overall survival in small-cell lung cancer

October 15, 2018 Research and Development, Sales and Marketing BMS< Opdivo, Bristol-Myers Squibb, Cancer, lung cancer, pharma

Bristol-Myers Squibb’s Opdivo (nivolumab) failed to deliver on its primary endpoint in a Phase 3 study in small-cell lung cancer, …
News

Health innovation system is broken and failing patients, new report argues

October 15, 2018 Sales and Marketing IP, industry, intellectual property, priofit, research

The pharmaceutical industry is incentivised to set high prices and deliver short-term returns to shareholders, rather than focusing on riskier, …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026